(7alpha,17beta)-7-(9-Bromononyl)estra-1,3,5(10)-triene-3,17-diol | CAS No. 875573-67-4
(7alpha,17beta)-7-(9-Bromononyl)estra-1,3,5(10)-triene-3,17-diol
Basic Information
CAS Number
875573-67-4
Molecular Formula
C27H41BrO2
Molecular Weight
477.53 g/mol
AD
Chemical Classification
Basic Physical Properties
Density
1.196
Synonyms & References
English
- (7a,17b)-7-(9-Bromononyl)estra-1,3,5(10)-triene-3,17-diol
- (7α,17β)-7-(9-bromononyl)estra-1,3,5(10)-triene-3,17-diol
- C27H41BrO2
- PUBCHEM_71463695
- AK102346
- Z3481
- ST24034963
- 573B674
- (7R,8R,9S,13S
- (7α,17β)-7-(9-Bromononyl)estra-1,3,5(10)-triene-3,17-diol (ACI)
MDL Number
MFCD16038540
FAQ
What regulatory guidelines apply to (7alpha,17beta)-7-(9-Bromononyl)estra-1,3,5(10)-triene-3,17-diol (CAS: 875573-67-4)?
The compound (7alpha,17beta)-7-(9-Bromononyl)estra-1,3,5(10)-triene-3,17-diol (CAS: 875573-67-4) is subject to regulatory guidelines such as GHS classification, REACH regulations, and FDA/EPA related requirements. It is important to adhere to these guidelines for safe handling, storage, and disposal. Specific regulations may vary based on the intended use and jurisdiction.
Are there alternatives to (7alpha,17beta)-7-(9-Bromononyl)estra-1,3,5(10)-triene-3,17-diol in synthesis?
In the synthesis of (7alpha,17beta)-7-(9-Bromononyl)estra-1,3,5(10)-triene-3,17-diol (CAS: 875573-67-4), there are alternative reagents such as other steroid derivatives, isomers, and analogs that can be used. Common substitutes include 17α-ethynylestradiol or other 17β-estradiol derivatives, depending on the specific synthetic route and desired properties.
What is the market or research trend for (7alpha,17beta)-7-(9-Bromononyl)estra-1,3,5(10)-triene-3,17-diol (CAS: 875573-67-4)?
The market for (7alpha,17beta)-7-(9-Bromononyl)estra-1,3,5(10)-triene-3,17-diol (CAS: 875573-67-4) is evolving with increasing research interest in its potential applications in pharmaceuticals and cosmetics. Market trends indicate growing interest in natural and synthetic steroid compounds, driven by advancements in medical research and consumer demand for effective skin care products.
How should waste containing (7alpha,17beta)-7-(9-Bromononyl)estra-1,3,5(10)-triene-3,17-diol (CAS: 875573-67-4) be handled?
Waste containing (7alpha,17beta)-7-(9-Bromononyl)estra-1,3,5(10)-triene-3,17-diol (CAS: 875573-67-4) should be collected in appropriate containers, labeled clearly, and disposed of by professional waste disposal services. Incineration is a common method for the safe destruction of this compound. Environmental protection precautions include proper ventilation and adherence to local waste management regulations to minimize environmental impact.
Related Compounds
![N-(2-Methoxyphenyl)-N-[(4-methylphenyl)sulfonyl]-beta-alanine structure](https://static.chemtradehub.com/structs/103/103687-96-3-8086.webp "N-(2-Methoxyphenyl)-N-[(4-methylphenyl)sulfonyl]-beta-alanine structure")
N-(2-Methoxyphenyl)-N-[(4-methylphenyl)sulfonyl]-beta-alanine
CAS Number:
103687-96-3
Molecular Formula:
C17H19NO5S
![5'-O-[Bis(4-methoxyphenyl)(phenyl)methyl]cytidine structure](https://static.chemtradehub.com/structs/112/112897-99-1-d1f4.webp "5'-O-[Bis(4-methoxyphenyl)(phenyl)methyl]cytidine structure")
5'-O-[Bis(4-methoxyphenyl)(phenyl)methyl]cytidine
CAS Number:
112897-99-1
Molecular Formula:
C30H31N3O7
![(3S,4R)-3-Hydroxy-2,2-dimethyl-4-[(3-oxo-1-cyclopenten-1-yl)oxy]-6-chromanecarbonitrile structure](https://static.chemtradehub.com/structs/121/121055-10-5-583d.webp "(3S,4R)-3-Hydroxy-2,2-dimethyl-4-[(3-oxo-1-cyclopenten-1-yl)oxy]-6-chromanecarbonitrile structure")
(3S,4R)-3-Hydroxy-2,2-dimethyl-4-[(3-oxo-1-cyclopenten-1-yl)oxy]-6-chromanecarbonitrile
CAS Number:
121055-10-5
Molecular Formula:
C17H17NO4
![Methyl 5-chloropyrazolo[1,5-a]pyrimidine-2-carboxylate structure](https://static.chemtradehub.com/structs/126/1263059-26-2-d6da.webp "Methyl 5-chloropyrazolo[1,5-a]pyrimidine-2-carboxylate structure")
Methyl 5-chloropyrazolo[1,5-a]pyrimidine-2-carboxylate
CAS Number:
1263059-26-2
Molecular Formula:
C8H6ClN3O2
You might also like
Compound Q&A
What is 6-Methyl-7-oxabicyclo[4.1.0]heptan-2-one (CAS: 21889-89-4)?
6-Methyl-7-oxabicyclo[4.1.0]heptan-2-one is a cyclic ketone with a molecular for...
21889-89-46-Methyl-7-oxabicycl...
Compound Q&A
What is 4-[(6-Methyl-2-pyrazinyl)oxy]benzoic acid (CAS: 906353-00-2)?
4-[(6-Methyl-2-pyrazinyl)oxy]benzoic acid is a chemical compound with the CAS nu...
906353-00-24-[(6-Methyl-2-pyraz...
Compound Q&A
What is 2-(2-Pyridinyl)-1,3-propanediol (CAS: 49745-42-8)?
2-(2-Pyridinyl)-1,3-propanediol (CAS: 49745-42-8) is a colorless to slightly yel...
49745-42-82-(2-Pyridinyl)-1,3-...
Compound Q&A
What is 2-(6-Chloro-2-pyridinyl)-2-phenylacetonitrile (CAS: 24783-42-4)?
2-(6-Chloro-2-pyridinyl)-2-phenylacetonitrile is an organic compound with the CA...
24783-42-42-(6-Chloro-2-pyridi...
Compound Q&A
What is 2-Oxopropanamide (CAS: 631-66-3)?
2-Oxopropanamide, also known as 2-aminoacrylic acid, is a chemical compound with...
631-66-32-Oxopropanamide
Compound Q&A
What is 2-Methyl-2-propanyl 4-(5-bromo-6-methyl-2-pyridinyl)-1-piperazinecarboxylate (CAS: 1289040-88-5)?
2-Methyl-2-propanyl 4-(5-bromo-6-methyl-2-pyridinyl)-1-piperazinecarboxylate (CA...
1289040-88-52-Methyl-2-propanyl ...
Compound Q&A
What is NAMPT inhibitor-linker 1 (CAS: 2241019-57-6)?
NAMPT inhibitor-linker 1 (CAS: 2241019-57-6) is a chemical compound designed as ...
2241019-57-6NAMPT inhibitor-link...
Compound Q&A
What is (2-(2,2,2-Trifluoroacetyl)pyridin-4-yl)boronic acid (CAS: 1310404-58-0)?
It is a chemical compound with the structure (2-(2,2,2-Trifluoroacetyl)pyridin-4...
1310404-58-0(2-(2,2,2-Trifluoroa...
Compound Q&A
What is 1-(2-Chlorophenyl)-6-(3,3,3-trifluoro-2-methylpropyl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one (CAS: 794568-90-4)?
1-(2-Chlorophenyl)-6-(3,3,3-trifluoro-2-methylpropyl)-1,5-dihydro-4H-pyrazolo[3,...
794568-90-41-(2-Chlorophenyl)-6...
Compound Q&A
What is Vinyl(chloromethyl)dimethoxysilane (CAS: 1314981-48-0)?
Vinyl(chloromethyl)dimethoxysilane is an organosilicon compound with the molecul...
1314981-48-0Vinyl(chloromethyl)d...
